Oxidative stress resulting from metal-ion misregulation plays a role in the development of Alzheimer's disease (AD). This process includes the production of tissue-damaging reactive oxygen species and amyloid aggregates.
Introduction
Alzheimer's disease (AD) is the most common form of dementia afflicting over 11 million individuals worldwide with this number expected to double by 2050. 1 One common feature of AD is unabated inflammation in the form of reactive oxygen species (ROS) in brain tissue. The production of ROS can come from the interaction of mis-regulated metal ions generating the buildup of amyloid (Ab) plaques and depletion of natural antioxidants in the brain tissue of the afflicted patient. This combination of ROS and Ab accumulation leads to the death of neurons and loss of cognitive function.
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Although transition metal ions play essential roles in human health, ion mis-regulation has been shown to result in interactions between amyloid and redox active metals. Higher levels of metal ions, specifically Cu and Zn, are known to catalyze the formation of amyloid plaques and have been found in higher concentrations in the tissue of AD patients compared to tissue from brain of non-AD afflicted donors.
3 This has been shown to result in the formation of the toxic fibrils derived from amyloid aggregation and generation of reactive oxygen species (ROS) by Fenton type chemistry, amongst other processes. 4 Overall this evolving hypothesis proposes an imbalance in Ab production/ clearance, with metal ion mis-regulation, and ROS playing a pivotal role in the development of AD. This cascades into a series of molecular events including gliosis, inflammation, and over-potentiation leading to excitotoxicity, plaques, tangles, oxidative stress, synaptic and neuronal dysfunction which ultimately and synergistically converge and result in the memory loss and dementia exhibited in patients.
5
Advances are continually being made in the understanding of how ROS and Ab accumulation is linked to neurodegeneration. 6 Specifically, whether the soluble fibrils and/or insoluble oligomers of Ab are responsible for the progression of the disease remains one of the major controversies with respect to this model. The former circumstance has gained traction thanks to recent work which has elucidated the early processes that lead to formation of toxic oligomeric species prior to mature fibril aggregation. 6 Regardless, the generation and uncontrolled mitigation of ROS is a concomitant outcome of amyloid aggregation. 4a,c,7 Understanding these pathways gives synthetic chemists targets at which to aim rational synthetic approaches toward producing small molecules capable of modulating these factors. One therapeutic strategy aimed at abating AD involves the use of metal-ion binding molecules that can restore the metal homeostasis in the brain. These can be categorized according to the following functionalities: (1) antioxidant hybrid molecules, (2) Ab targeting and (3) enzyme inhibiting activity. 8 Our group has previously studied hybrid molecules composed of a chelator moiety in conjunction with a pyridol functionality which we showed to be responsible for protection against reactive oxygen species in cells. 9 Our studies demonstrate that the fusion of functional groups can engender the positive characteristics of the parent molecules onto the product system. However, they have been largely hindered for in vivo work by solubility and biocompatibility. Herein we take a novel approach to the molecular design of agents targeting features of AD by fusing naturally occurring antioxidant constructs to metal binding moieties. Lipoic acid can act as a coenzyme in metabolic routes of cells, including glutathione synthesis, the most important natural antioxidant in the brain. 10 There have been several in vitro studies suggesting that a-lipoic acid (LA) and its reduced form dihydrolipoic acid (DHLA) can inhibit the formation of amyloid fibrils (fAb), as well as destabilization of preformed fAb. 11 Here, we integrate lipoic acid into the metal binding cyclen (1,4,7,10-tetraazacyclododecane) scaffold that our previously reported systems resemble based on the metal binding heterocyclic core.
9
This new system is designed to utilize the lipoic acid component to provide multiple modes of ROS targeting activity while tuning the metal binding capacity of the metal-scavenging cyclen core. We report, an array of ex vivo and in vitro experiments that are carried out to deduce the ability of the water soluble, hybrid lipoic cyclen (1) molecule ( Fig. 1 ) to modulate amyloid aggregation and oxidative stress while increasing biocompatibility of the original scaffold, cyclen. Most relevant to this work are cellular assays (utilizing HT-22 neuronal cells) which indicate that 1 can combat cell toxicity induced by amyloid in the presence or absence of copper.
Experimental

General methods
All reagents used were obtained from commercial sources and used as received, unless noted otherwise.
1
H NMR spectra were obtained on a 400 MHz Bruker spectrometer, using deuterated solvents (CDCl 3 , D 2 O) with tetramethylsilane as internal reference (in parts per million; Me 4 Si, d = 0.00 ppm).
13 C NMR spectra were obtained at 100 MHz using CDCl 3 as internal reference (d = 77.36 ppm) . For proper identification of the NMR signals the following abbreviations were used: s = singlet, d = doublet, t = triplet, m = multiplet. When noted, purification of the compounds was accomplished with flash chromatography using silica gel (63-200 mm) . TLC plates were developed using iodine and UV light, when possible. Electronic absorption spectra were recorded on a DU 800 UV-Vis spectrophotometer (Beckman Coulter) using a 1 mL quartz cuvette with a 1 cm path length or a Molecular Devices Kinetic Microplate Reader for colorimetric assays. ESI-MS experiments were carried out using an Agilent 6224 Accurate-Mass Time-Of-Flight (TOF) MS. HPLC chromatograms were obtained using a C8 reversed phase column, unless noted otherwise, with 100% MeOH at a flow rate of 0.5 mL min À1 on an Agilent 1100 series instrument, which was coupled to Bruker Daltonics Esquire 6000 ESI-MS. Preparation of dibenzyl 1,4,7,10-tetraazacyclododecane-1,7 dicarboxylate (3) was produced according to a method by De Leon et al.
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Synthesis (AE)-5-(1,2-Dithiolan-3-yl)pentanoyl chloride (2). To a stirred solution of thionyl chloride (1.4 mL, 7.5 mmol) in CH 2 Cl 2 (30 mL) at 0 1C was added a CH 2 Cl 2 solution of lipoic acid (3.0 g, 5 mmol), dropwise over 1 h. The mixture was allowed to stir for an additional 3 h at the same temperature. The solvent was removed under vacuum (without any heating) and used without further purification in the next step. The reaction proceeded with quantitative yield. 13 Preparation of the dibenzyl 4-(5-(1,2-dithiolan-3-yl)pentanoyl) -1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate (4 0, 32.1, 34.9, 38.5, 40.3, 42.7, 46.3, 47.8, 50.6, 56.4, 67.1, 128.2, 136.4, 156.5, 172.6 Preparation of 5-(1,2-dithiolan-3-yl)-1-(1,4,7,10-tetraazacyclododecan-1-yl)pentan-1-one (1) . Boron trichloride in CH 2 Cl 2 (1 mL, 8.5 mmol) was carefully added to a previously purged flask with nitrogen, containing 4 (1.2 g, 1.9 mmol). The white suspension was then allowed to stir for 24 h. Excess CH 2 Cl 2 was removed under reduced pressure. To the resultant yellow solid, MeOH was added carefully and rotavaped down (3Â). The residue was resuspended in water and HCl was added, and the aqueous layer washed with EtOAc, and lyophilized to yield the product as a yellow solid in 89% yield. mp 195-198 40.3, 43.0, 43.7, 44.7, 46.2, 47.1, 56.5, 172.0; MS (ESI, CH Copper binding studies. Aqueous stock solutions were prepared by weight for both ligands: 1 and cyclen. The molar concentrations of these solutions were 16.7 mM and 12.8 mM for 1, and 10.2 mM for cyclen. A copper nitrate aqueous stock solution with a molar concentration of 33.4 mM was also prepared by weight. Deionized and ultra-pure water was obtained from a four-stage Millipore filter system and used to prepare all solutions. Copper-ligand solutions for spectroscopy measurements were obtained by mixing known amounts of copper and ligand stock solutions. The copper concentration was kept constant at 3.4 mM for all the samples. A 0.10 M acetate buffer (pH = 5.0) was also added so that the final buffer concentration was 0.01 M. To approximately maintain a constant ionic strength, a 1.0 M solution of sodium nitrate was also added so that its final concentration was 0.10 M. The absorption spectroscopy measurements were made on a UV-vis DU 800 spectrophotometer (Beckman Coulter) using a 1 cm path length cuvette, at room temperature. The obtained results are reported as normalized absorption spectra by calculating the molar absorption coefficient, e, with respect to the copper concentration, C M . In the absence of ligand, the absorption spectrum of the copper salt shows a weak band with a maximum at the wavelength (l max ) of 770 nm. Note that l max = 810 nm corresponds to the hydrated
2+ species. The observed blue shift can be related to the complex formation between copper and acetate ions (formation constant, b = 4 Â 10 3 , 25 1C). A stronger shift was observed in the cyclen case. This can be attributed to a corresponding stronger binding interaction with copper ions and is consistent with reported binding studies. 14 Biological methods. For the biological assays, HT-22 neuronal cell line from mouse hippocampus (passages 10-20) was used and incubated at 37 1C in a 5% CO 2 humidified atmosphere in Dulbecco's Modified Eagle Medium (500 mL) containing 100 units per mL penicillin/100 mg mL À1 streptomycin 100Â (5 mL), 2 mM glutamine (100 mM, 5 mL), and charcoal stripped fetal bovine serum (15%). To prepare dilutions of compounds the same media was used excluding the addition of the serum and antibiotics. Human Embryonic Kidney (HEK 293) cells were used as a control cell line and were maintained in a manner similar to the HT-22, using regular FBS instead of charcoal stripped. Amyloid-b (Ab) peptide experiments Ab 1-40 preparation. For all the Ab experiments, Ab 1-40 (21st Century Biochemicals) was used as the ammonia salt, obtained by dissolving Ab in chelex-treated milliQ water (treated overnight), prepared as a 1% v/v solution of NH 4 OH to yield a final concentration of 200 mM, divided into aliquots, lyophilized and stored at À80 1C until use.
MTT assay. Cells were seeded in a 96 well plate at a density of 5000 cells per well (in 100 mL complete medium). After 24 h cells were treated with compounds, Ab, Cu 2+ , or a combination, and incubated for 48 h at 37 1C. After the incubation time, media was discarded and cells were then treated with 100 mL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (1 mg/1 mL in serum free media) and incubated for 4 h at 37 1C. Media was discarded and the formazan precipitate solubilized in 100 mL of DMSO, rocked for 5 minutes and the absorbance (A 540 ) was measured using a Molecular Devices Kinetic Microplate Reader; the data obtained was processed using MasterPlex 2010 software for EC 50 calculations and Stat View for the ANOVA tests. DPPH assay. A 2,2-diphenyl-1-picrylhydrazyl (DPPH) stock solution was prepared by dissolving 25 mg of DPPH solid in 100 mL of absolute EtOH. The working radical solution was prepared by dilution with absolute EtOH to an absorbance of 1.3 at 512 nm.
Stock solutions of the compounds tested were dissolved in deionized H 2 O and EtOH 95% for the BHT solutions respectively and serial dilutions were made to get different concentrations. For the analysis 2 mL of the solutions were incubated with 2 mL of DPPH working solutions in the dark for 24 h as well as 2 mL of DPPH working solution with 2 mL of H 2 O or EtOH to serve as blank. Analysis of the solutions was performed as follows: 1 mL of the sample solution was diluted with 1 mL of H 2 O shaken and the absorbance was measured at 515 nm.
Determination of amyloid aggregation based on transmission electron microscopy (TEM). Samples for transmission electron microscopy were prepared using a 15 mM solution of Ab dissolved in milliQ water previously treated with chelex, 30 mM CuCl 2 and 50 mM 1 respectively, incubated overnight at 37 1C with continuous agitation and centrifuged before applying them to the grids taking the bottom part of the solution. Glow discharged grids (Formar/Carbon coated 200 mesh, Electron Microscopy Sciences) were treated with one drop from the different solutions for 5 minutes at room temperature. Excess of sample was removed with a filter paper and washed three times with doubly distilled H 2 O, stained with 1% uranyl acetate for 15 minutes, excess of uranyl acetate was absorbed with a filter paper, samples were dried at room temperature and analysed with a JEOL 2100 at 200 kV, 8k magnification.
Tyr-10 intrinsic fluorescence assay. Solutions containing a final concentration of 15 mM Ab, 30 mM CuCl 2 and 50 mM 1 were respectively dissolved in 1Â PBS, following this order of addition: compound, peptide, copper. Following incubation for 1 hour at 37 1C, fluorescence intensity was measured (Ex 270 , Em 290 ). Each measurement was made in triplicate. Note: several factors should be considered when working with amyloid protein for studies such as this. Aggregation of Ab can occur in several stages and therefore solutions are generally not very stable for long periods of time. Studies following Ab aggregation by fluorescence involve the monomerization of any previous aggregate formed in the peptide with hexafluoroisopropanol (HFIP). Kinetic studies following aggregation of Ab have shown the same results of amyloid aggregation with and without treatment with HFIP within one hour after the reactions have started. However after that hour, the solution without HFIP becomes unstable. 15 Therefore the approach here presented is based analysing only the first hour of incubation of the protein, avoiding one extra element (HFIP) that could interfere with aggregation and solubilisation of the protein as well with the interaction of this solvent with the intrinsic fluorophore tyrosine. Determination of amyloid aggregation based on native gel electrophoresis with western blotting. Solutions prepared for the Tyr-10 fluorescence assay were analysed by native gel electrophoresis with western blotting using anti-Ab (6E10) as primary antibody. Each sample contains 15 mM Ab, 30 mM of CuCl 2 and 50 mM of 1 respectively as well as a sample of Ab 15 mM containing SDS as a control for the monomeric species, were separated using a 10-20% Tris-tricine gradient gel (Invitrogen). The gel was transferred to a PDVF membrane (1 h, 100 v, 4 1C) and blocked overnight with a solution of 3% w/v bovine serum albumin (BSA) dissolved in Tris-buffered saline containing 0.1% Tween 20 (TBST), the membrane was treated with primary antibody 6E10 (1 : 1000; 2% BSA in TBS-T, Covance) for 4 hours at room temperature. The membrane was then incubated with the horseradish peroxidase-conjugated goat anti-mouse antibody (1 : 10 000) in 2% BSA in TBS-T for 1 hour at room temperature. The Thermo Scientific Supersignal West Pico Chemiluminescent Substrate was used to visualize protein bands.
Two-dimensional (2D) Docking studies of 1 with AutoDock Vina. Docking studies of 1 or cyclen were performed using a previously determined NMR model of Ab obtained in an aqueous solution (PDB 2LFM) and previously used for metal chelator analysis. 16 out of 20 conformations reported in the PDB file, the one that correlated better with the 2D NMR studies was selected. The ligand structure was optimized for the docking studies in ChemBio3D Pro 12.0 with the MM2 energy minimization. AutoDock Tools was used to prepare Ab protein optimized structural files that were run with AutoDock Vina using PyRx to obtain the binding energies. The search space dimensions were selected in order to contain the entire peptide with an exhaustiveness of 1024 runs. The visualization of the docking results were made using PyMol.
Discussion
Design and synthesis of 1 Molecule 1 contains the biological antioxidant, lipoic acid, tethered to a metal binding domain, cyclen. The addition of lipoic acid to this construct abates the oxidative stress that has been shown to modify proteins, lipids and DNA resulting in unstable or less functional systems and giving rise to mutations.
We therefore set out to fuse the natural antioxidant lipoic acid onto a well-characterized Cu 2+ chelator (cyclen). This design targets known molecular assaults associated with AD: mis-regulated metal ions alone and those interacting with amyloid, along with targeting ROS generation. Molecule 1 was converted from a high-affinity system (cyclen) to a moderate metal binding structure via an acyl linkage to lipoic acid utilizing a straightforward methodology involving three steps (Scheme 1). Specifically, the synthesis of 1 begins with the protection of 1,7-amines of cyclen with benzyl chloroformate following previously reported methods. 12 Concurrent conversion of lipoic acid to lipoic chloride with thionyl chloride in dichloromethane proceeds smoothly in quantitative yield. These two products are then combined to react in the presence of triethylamine to form an amide bond in position-10 of cyclen through a nucleophilic substitution at the carbonyl group. Di-substitution of cyclen with lipoic chloride is observed as trace products and can be separated using column chromatography. Finally, deprotection of the Cbz group with boron trichloride gave the desired product. The HCl salt of 1 was isolated as a water soluble yellow powder, stable to the atmosphere for long periods of time.
Copper binding of cyclen is attenuated by addition of lipoic acid
The main antioxidant defense of the cell against ROS is primarily the copper containing enzyme superoxide dismutase I. Therefore, copper metabolism inside the cell is an interesting aspect considering that either the overload or deficiency of this metal will result in an oxidative challenge in terms of cellular health.
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Moreover the brain is particularly susceptible in the case of copper mis-regulation because it is highly sensitive to oxidative stress as a consequence of a variety of factors. Furthermore, since copper uptake in the cell is strongly influenced by glutathione levels, it is important to consider that glutathione is a copper chelator as well as a natural antioxidant in the brain, thus playing an important role in the generation of ROS. 18 Therefore the design of a small molecule targeting metal ions must involve careful tuning of the metal binding core to avoid disturbing the natural homeostasis of copper inside the cell. Spectrophotometric methods for determination of the binding affinity of 1 were carried out to verify that the acyl group of the (Fig. 2a) and 1 (Fig. 2b) . These spectra were obtained as a function of ligand concentration at constant copper(II) concentration. For the molecules investigated, cyclen and 1, l max shifts towards shorter wavelengths, compared to the copper starting material, as ligand concentration increases and approaches a saturation value at high ligand concentration; l max = 590 nm and 670 nm for cyclen and 1 respectively. Both complex binding constant (K/mM À1 ) values were determined using a fitting function based on the relative change of copper absorption coefficient, e/e 0 , with respect to the ligand-copper molar ratio (C L /C M ), where e 0 is the absorption coefficient of copper in the absence of ligand (details in ESI †). The extracted values are reported in Table S3 (ESI †) . The results, presented in Fig. 2 , support a 1 : 1 binding stoichiometry for both cyclen (as expected) and 1. For 1, a moderate binding of 6.4 AE 1.7 mM À1 was calculated for these conditions. For cyclen, however, our experimental data cannot be used to extract K because of very strong binding between cyclen and copper. Nonetheless, the fitting function can satisfactorily describe these data only if K is higher than 10 2 mM À1 . Indeed, for the copper-cyclen complex in aqueous solutions with 0.1 M NaNO 3 the literature value of K is 1.8 Â 10 16 mM À1 . 14 This is consistent with the expected acyl attachment of 1 reducing the donor capacity of the N-atom in the N-heterocyclic ring thereby lowering the binding capacity. Overall these results indicate that the employed substitution methods provide a controlled tuning of metal-binding affinity as expected. A moderate-weak metal chaperone system like 1 is projected to exhibit smaller perturbations in metal-ion trafficking pathways, making it a more suitable molecule for intracellular activity.
has enhanced biocompatibility
For 1 to be suitable as an anti-oxidant and metal binding agent in biological systems it must exhibit minimal toxicity was therefore explored to establish the biocompatibility of this novel hybrid construct as well as define the effects of integrating the lipoic component onto the heterocyclic core. The 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was utilized in order to evaluate 1 for cytotoxicity. The HT-22 neuronal cell line was utilized for this study due to their hippocampal origin (the hippocampus being the center of learning and memory in the brain). Moreover, an increased degenerative effect is observed in this region of the brain in AD patients making this cell line appropriate for these studies. As shown in Fig. 3 , following incubation of cells for 48 h with 1 nM to 10 mM 1, an EC 50 value of 750 mM was derived corresponding to the concentration necessary to elicit toxicity in 50% of cells studied. In comparison, the parent cyclen backbone showed an EC 50 of 80 mM (Fig. S1 , ESI †). This result indicates that 1 is 9.4Â less toxic than cyclen alone. This decrease in toxicity is believed to be a result of the addition of lipoic acid to the construct. This increased biological tolerance translates to other cell lines as well. HEK-293 (human embryonic kidney) cells were co-incubated with 1 or cyclen resulting in a B33% increase in the concentration of 1 required to induce cell death compared to cyclen (Table 1 ). This micromolar toxicity provided us with a wide range of concentrations for the studies presented herein and supports an overall biological tolerance for future in vivo work.
1 protects against amyloid and Cu 2+ toxicity in neuronal cell culture Amyloid has been shown to cause neuronal cell death by a number of pathways upon entering the cell by endocytotic View Article Online pathways. Given the low toxicity of 1, the potential of 1 to reduce cell death induced by Ab was explored. Neuronal HT-22 cells were exposed to Ab and a concentration dependent toxicity was observed as shown in Fig. 4 . A concentration of 15 mM Ab consistently caused B20% cell death and was therefore used for subsequent rescue studies using 1 discussed herein. As shown in Fig. 4 , a single dose of 1 was added in the range of 50 to 120 mM resulting in a concentration dependent response of increased cell viability. This indicated that 1 was capable of restoring cellular health impaired by Ab. Specifically, the largest protection (17%) was observed for the samples co-incubated with 120 mM 1. Statistical significance (p o 0.005) for samples of 100-120 mM 1 was observed (Fig. S2, ESI †) . A small protection against copper induced toxicity was observed for 1 at higher concentrations as well (Fig. S3 , ESI †). We did not observe any protection with cyclen at the same concentrations. In fact, an increase in cell death occurred and is consistent with toxicity data of cyclen (Fig. S1 , ESI †). Subsequently identical experimental conditions were carried out with the sequential addition of 15 mM CuCl 2 and Ab. As expected, a decrease in cell viability was observed (37%). The addition of increasing concentrations of 1 to copper treated cells (Fig. 4) showed a statistically significant ability to protect against Ab + Cu 2+ induced toxicity in all concentrations studied ( p o 0.005, 50-80 mM; p o 0.05, 100-120 mM). In fact the 120 mM sample of 1 almost completely restores the viability of cells resulting in a net increase in viability of 34% from the Cu/Ab treated control, resulting in 97% viability. The results indicate that 1 is a potent rescue molecule capable of abating the combined degenerative effects of copper ions in the presence of amyloid.
Defining the observed therapeutic effect of 1
In order to elucidate the mode(s) of action for the protective capacity of 1, a gamut of spectroscopic and biological studies were carried out. As stated previously, amyloid and metal ion regulation are closely tied to oxidative stress levels in cells. The result of an imbalance in these species is gaining credence in the metal based hypothesis of AD. The following experiments were designed to dissect the synthetic rationale of 1 and how it relates to the observed protective nature reported above. In addition, amyloid interactions were also explored. 1 acts as a radical scavenger. As radicals are one product of miscompartmentalized metal ions, the radical scavenging capability of 1 was tested using the DPPH assay. BHT (butylhydroxytoluene) was used as a positive control due to its known antioxidant properties. Fig. 5 shows that high concentrations (1250 mM) of BHT are capable of quenching 80% of the DPPH radical while cyclen shows no activity. Compound 1 at 1250 mM is equally proficient with BHT at quenching an equivalent amount of radical, following a dose response trend up to 62.5 mM concentration. Comparison of the concentration range of 1250 to 62.5 mM of the radical scavenging capacity of compound 1 with the parent cyclen backbone shows that the activity observed in 1 is improved as a result of the lipoic acid moiety. It should be noted that the concentrations required to quench radicals are parallel to those utilized in the cellular assays reported above and support the hypothesis that 1 could be acting as an intracellular antioxidant via radical scavenging.
Lipoic acid can act as a coenzyme in several metabolic and biosynthetic pathways, including glutathione synthesis. Given the possibility that 1 could be metabolized into glutathione, the major antioxidant defense found within the intracellular domain in the brain, we investigated the possibility of 1 supplementing GSH pathways as a potential mode of action for the protection observed in Fig. 4 . For this study, HT-22 cells were co-incubated with the small molecule BSO (2-amino-4-(butylsulfonimidoyl)butanoic acid) known to inhibit the synthesis of glutathione in cells. This results in oxidative stress and cellular death as shown in Fig. S4 (ESI †) . 19 The GSH-Glot
Glutathione Assay was used to measure GSH levels following 1 addition. The results indicate that GSH levels are depleted in the presence of BSO as expected but are not restored by 1 addition. These results support the conclusion that the 1 molecule does not supplement the GSH antioxidant pathway and likely provides protective capacity via radical scavenging and metal-ion sequestration. 4a,c,7 This hypothesis is further supported by previous work that has shown the LA and DHLA molecules can also act as scavengers for ROS due to a relatively low redox potential (À320 mV). Such studies have also shown cellular protection from ROS generating insults as well. 10a-d,11,20 1 modulates Ab aggregation induced by Cu 2+ . A growing consensus relates the toxicity of amyloid to the morphology of the protein in its aggregated form. 6 We therefore set out to explore the effect of 1 on the morphology of aggregated amyloid. TEM can be used to visualize the morphology of proteins, specifically amyloid. 16a This makes it a powerful tool for understanding the effects of metal-ions on aggregation and the changes induced by small molecules like 1. For the studies presented herein, a 15 mM amyloid solution was prepared in milliQ water previously treated with chelex. To these solutions, 30 mM CuCl 2 and 50 mM 1 were added, respectively, incubated overnight at 37 1C with continuous agitation and then centrifuged before applying them to the glow discharged grids and stained. Fig. 6a shows the sample containing only Ab with morphology similar to fibrils reported by others. It is interesting to note that the signal generated after addition of 1 did not show equivalent capacity to restore the fluorescence signal.
To corroborate the results obtained with the Tyr-10 assay and the TEM images, polyacrylamide gel electrophoresis under native conditions followed by western blot was used to identify the aggregation level of amyloid as well as the capability of 1 to reduce the aggregate size of the protein. As shown in Fig. 8 , the amyloid solution aggregates naturally, presumably in fibrillar forms shown in the previous TEM experiment. The addition of copper to amyloid induces the formation of larger M.W. species of Ab (seen as an increase in the intensity of the signal toward the top of the lane) which may be correlated to oligomer formation. 
View Article Online
The addition of 1 results in a reduction of aggregate size (the high M.W. species on the gel image) is observed and correlates with the results obtained with the Tyr-10 fluorescent assay. The same behaviour is shown in the presence of the parent molecule, cyclen, which could be attributed to its copper chelating ability. This is consistent with previously reported literature. 16a,c,d,22 Two-dimensional (2D) 1 H-15 N heteronuclear single quantum
correlation (HSQC) NMR measurements
Based on the aggregation work described above, it was postulated that 1 could be acting in a protective manner via interacting with amyloid in a fashion that prevented aggregation and thus toxicity. Therefore 2D N-labeled Ab in the absence and presence of a 1.5-fold excess of 1 was acquired. The spectra were acquired at low Ab concentration (20 mM) and 5 1C to hinder aggregation. Interestingly, addition of 1 did not induce marked shifts on the Ab cross-peaks as others have reported 16b (Fig. 9 ), but did increase the intensities of most cross-peaks (Fig. S6 , ESI †). The absence of cross-peak shifts indicates that 1 does not bind directly to monomeric Ab. However, the increased cross-peak intensities show that 1 must interact somehow with Ab. A plausible interpretation of these findings is that, without the compound, Ab has a tendency to oligomerize, and chemical exchange between the monomeric form and oligomers causes broadening of the 1 H-15 N HSQC cross-peaks of the monomer, which results in decreased cross-peak intensities. Since most of the peptide is involved in the aggregation, all signals are expected to be broadened to some degree. The broadening comes not only from the slower motions of the oligomers but also from chemical exchange between the monomer and oligomers. Chemical exchange will broaden more strongly the signals that have larger chemical shift change between oligomer and monomer, and this is rather unpredictable; hence, it is natural to observe a relatively random distribution of the amount of broadening in the cross-peaks (Fig. S6c, ESI †) . In this interpretation, addition of 1 increases the cross-peak intensities because it prevents aggregation, likely by binding to the nascent oligomers and forming a non-productive edge that hinders oligomer growth. . These results indicate that the lipoic addition to cyclen correlates to an interaction with amyloid capable of modulating the structure of amyloid as evidenced by these calculations along with the Tyr-10 and HSQC results. Moreover one can also appreciate in Fig. 10b the interaction of 1 considering the electron density of Ab which would help to explain the increase of intensity signals in the HSQC experiments, which indicates that affects this binding site of the protein in a manner that prevents its interactions with other monomers, therefore reducing the aggregation process, which translates into more flexible residues in Ab increasing the signals in the HSQC experiments.
Computational calculations support the potential of 1 having ability to cross the blood brain barrier (BBB)
The potential of 1 to cross the blood brain barrier was assessed by theoretical calculations of log K ow . The results were obtained using the software EPI suite version 1.68 which uses the atom/ fragment contribution method (Moriguchi's method). Systems with log K ow values 45 are considered to have high bioaccumulation potential similar to Lipinsky's rule of five. Conversely, compounds with low log K ow (o1) will correlate to poor permeation and biodistribution. 23 Table 2 presents the calculated coefficient values according to the linear and non-linear descriptors from already known compounds following the Moriguchi's rules. The results View Article Online obtained for the value of log K ow (1.1710) are within the range (log K ow = 1-3) of previously described compounds 24 and support that 1 can potentially cross the BBB. Comparing the results to those obtained with cyclen (log K ow = À1.8270, Table S1 , ESI †) shows that the addition of lipoic acid to this scaffold not only increases bioavailability but also increases the ability of biodistribution across membranes, specifically the blood brain barrier.
Conclusions
The hybrid molecule 1 has shown low toxicity and the ability to protect neuronal cells against death induced by Ab + Cu, two molecular components associated with the pathology of AD. Molecule 1 is capable of potent antioxidant activity through radical scavenging and moderate binding of copper ions. Moreover, 1 is capable of breaking apart amyloid aggregates as evidenced by TEM images of 1 with amyloid + Cu and interacts with amyloid in a non-aggregate producing manner according to 15 N HSQC studies. Overall this work shows that the rationale used to produce the water soluble and air stable compound 1. This compound can serve as a tool to study the role of Ab, copper and ROS in neuronal toxicity and could serve as a platform for the development of lead compounds for the treatment of neurodegenerative disorders such as AD. 
